COMP <GO>
SDGR vs AUPH // EV/EBITDA & P/E VALUATION
Schrodinger Inc. (NASDAQ) VS. Aurinia Pharmaceuticals Inc (NASDAQ) • 15-METRIC TALLY: SDGR 2
— AUPH 7
■ METRIC PARITY
LAST: $29.99 (-2.85%) • MKT CAP: $2.24B
valuation
—
LAST: $17.21 (-0.86%) • MKT CAP: $2.29B
valuation
21.1x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SDGR VS. AUPH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SDGR | AUPH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 55.70% | 88.50% | -32.80 | AUPH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 16.50% | -51.50 | AUPH | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 21.1x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 0.56% | 5.92% | -5.36 | AUPH | /fcf-yield <GO> |
| Operating Margin | -60.00% | 37.10% | -97.10 | AUPH | /operating-margins <GO> |
| Net Profit Margin | -40.40% | 68.00% | -108.40 | AUPH | /net-margins <GO> |
| Revenue Growth (YoY) | 23.30% | 20.40% | +2.90 | SDGR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.64 | 8.33 | -5.69 | AUPH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 53.0 | 49.5 | +3.47 | SDGR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 6.7x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.24B | $2.29B | -$46.4M | AUPH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SDGR REV | AUPH REV | SDGR GROSS % | AUPH GROSS % | SDGR FCF | AUPH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $255.9M | $283.1M | 55.7% | 88.5% | $12.5M | $135.7M |
| FY 2024 | $207.5M | $235.1M | 63.6% | 88.0% | -$164.7M | $44.4M |
| FY 2023 | $216.7M | $175.5M | — | — | -$136.7M | -$33.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SDGR // BETA —
AUPH // BETA —